Drug Information

Drug General Information
Drug ID
D01SHR
Former ID
DNC008661
Drug Name
((3R,4R)-4-(o-tolyloxy)chroman-3-yl)methanamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529620]
Structure
Download
2D MOL

3D MOL
Formula
C17H19NO2
Canonical SMILES
CC1=CC=CC=C1OC2C(COC3=CC=CC=C23)CN
InChI
1S/C17H19NO2/c1-12-6-2-4-8-15(12)20-17-13(10-18)11-19-16-9-5-3-7-14(16)17/h2-9,13,17H,10-11,18H2,1H3/t13-,17-/m1/s1
InChIKey
RQRGTZIPGLRQOJ-CXAGYDPISA-N
PubChem Compound ID
44593693
Target and Pathway
Target(s) Sodium-dependent noradrenaline transporter Target Info Inhibitor [529620]
Sodium-dependent serotonin transporter Target Info Inhibitor [529620]
KEGG Pathway Serotonergic synapse
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway Adrenaline and noradrenaline biosynthesisP04373:5HT1 type receptor mediated signaling pathway
5HT2 type receptor mediated signaling pathway
5HT3 type receptor mediated signaling pathway
5HT4 type receptor mediated signaling pathway
Reactome Na+/Cl- dependent neurotransmitter transporters
WikiPathways Monoamine Transport
NRF2 pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsWP727:Monoamine Transport
SIDS Susceptibility Pathways
Synaptic Vesicle Pathway
Serotonin Transporter Activity
References
Ref 529620Bioorg Med Chem Lett. 2008 Aug 15;18(16):4495-8. Epub 2008 Jul 17.Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.
Ref 529620Bioorg Med Chem Lett. 2008 Aug 15;18(16):4495-8. Epub 2008 Jul 17.Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.